Latest Event Updates

In Vitro Fertilization (IVF) Market in Asia Pacific Will Reach $4.2 Billion by 2020 – Allied Market Research

Posted on Updated on

According to a new report by Allied Market Research, titled, “In  Vitro  Fertilization  Market  in  Asia  Pacific   Country  Analysis  by  End  Users  (Clinics,  Hospitals,  Surgical  Centers,  Clinical  Research  Institutes,  Banks),  Number  of  Cycles,  Revenue,  Share,  Growth,  Trends,  and  Forecast  through  2020,” the IVF market in Asia Pacific stood at $1.3 billion in 2012 and is estimated to be $1.4 billion in 2013. The IVF market in the region is forecast to grow to $4.2 billion in 2020 at a CAGR of 17.1% during 2013 – 2020. The overall number of IVF cycles performed in the region stood at 329.3 thousand in 2013. The number of IVF cycles in Asia Pacific will continue growing with a fast pace during 2013 – 2020 to reach 779.4 thousand in 2020, registering a CAGR of 13.1% during the evaluation period.

To request a sample of the report, visit us at http://www.alliedmarketresearch.com/in-vitro-fertilization-asia-pacific-market

In 2010, the Asia Pacific IVF market grown to become a $1 billion industry. The growth trajectory further consolidated with growing government interventions and support, especially in countries such Japan, Korea and Singapore where the lower fertility, aging population and lack work force has triggered severe implications.

Although the largest number of IVF cycles is performed in India, Australia is the largest contributor to overall region’s revenue. Australia IVF market is estimated to be worth $369.7 million in 2013. The market is further expected to become a billion dollar industry in the country, garnering $1.1 billion in 2020 at a CAGR of 17.5% during 2013 – 2020. However, India IVF market is expected to be fastest growing country market with a CAGR of 17.9% during the same period. The faster revenue growth in India IVF market will be supported by the growth in cost per cycle due to increasing sophistications of procedures and advancement in technology.

Fertility clinics and specialty hospital plays crucial role in providing IVF treatment to couple seeking assistance for infertility treatment. With the success of specialized fertility centers such as Virtus Health Ltd (Australia) and Fortis Bloom Fertility and IVF Center (India), the IVF market in Asia Pacific has taken a leap forward. Specialized IVF clinics have been dominant in performing IVF cycles with about 161 thousand procedures performed in 2012. The segment is expected to have 371 thousand IVF cycles by the end of 2020 at a CAGR of 12.1% during 2013 – 2020, closely followed by Hospitals segment at 351 thousand in the same year. Surgical centers will exhibit fastest growth rate during the period; however, largely due to lower volume.

Advertisements

Digital Pathology Market is Expected to Reach $5.7 Billion, Globally, by 2020

Posted on Updated on

According to a new report by Allied Market Research titled “Digital Pathology Market – Global Industry Analysis, Size, Growth Trends, Share, Opportunities and Forecast 2012  2020,” the global digital pathology market was valued at $2.2 billion in 2013, is estimated to reach $5.7 billion by 2020 at a CAGR of 14.3% during 2013-2020. North America led the overall digital pathology market, closely followed by Europe. The two regions accounted for about 79% of total revenue in 2013. However, their collective share will be reduced to 2/3rd of the total revenue generated in 2020, largely due to the growing dominance of Asia Pacific region.

To request a sample of the report, visit http://www.alliedmarketresearch.com/digital-pathology-market

Digital pathology is an emerging technology in the pathology field, where the glass slides are converted into digital images for easy viewing, analysis, storage and management of the data collected. The development and recent technological findings in the digital pathology market would push the conventional pathology to more advanced and strategic levels. Due to the advancement in the technology, concerns such as lack of qualified pathologists would be addressed more effectively. “The decentralization approach in the digital pathology market will make huge difference in the field of pathology. The major factors influencing the market growth are cost efficient diagnosis, efficiency in mundane workflow and analysis,” according to Allied Market Research analysts Debbie Shields and Rohini Patil. “These factors are impacting the outcome of the overall diagnosis process. The efficient technology impacts time, productivity and the level of patient care. However, the factors restraining the market growth are the lack of reimbursement policies by the governments, inefficient infrastructure and delayed approvals,” explained the analysts.

The digital pathology market is segmented based on components, namely whole slide imaging (WSI), image analysis – informatics & storage, and communication & integrated platforms. The WSI segment is largest contributor to the overall global digital pathology market revenue in 2013. Though the segment will partially lose market share over the next seven years, it will continue to be the largest digital pathology product segment throughout the forecast period. This is largely due to its capability to convert and share glass slides digitally with ease, safety and at lower cost. The image analysis-informatics market is expected to have the highest potential during 2013-2020, when compared to the other components. The gradual refinement of analysis software to provide higher accuracy in the analysis of digital slides will enable the faster growth of the segment.

The end users segment of the digital pathology market is segmented into pharmaceutical research, clinical organizations and educational institutes. The pharmaceutical research accounted for the largest revenue in 2013 and will continue to dominate the global pathology market throughout the analysis period at highest CAGR of 16.9% during 2013 – 2020. The rise in revenue is due to the increase in the use of digital pathology systems (DPS) for drug development and discovery.

The report segments the global digital pathology market into four major regions namely North America, Europe, Asia and Row. North America is the largest segment due to the higher adoption of DPS in most of the labs across the region. The Asian market is expected to have the highest CAGR compared to the other regions during the analysis period. The rise in the Asian market is due to the demand for better infrastructure and need for skilled pathologists.

The key strategies that are implemented by the manufactures to increase the adoption, development and sales of the DPS are product launches, agreements and partnerships. Most of the product launches target product up-gradation with new and improved benefits, example- 3DHISTECH, in 2013, launched Pannoramic 250 Flash – a next generation slide scanner, which has high speed and faster scanning capacity.

The key companies profiled in the report are Definiens AG, Digipath, Inc., Leica Microsystems Gmbh, Ventana medical systems, Inc., Nikon Corporation, Visiopharm, Philips healthcare, Indica Labs, Inc, Omnyx LLC and 3DHISTECH, Ltd.

Hadoop Market is Expected to Reach $50.2 Billion, Globally, by 2020 – Allied Market Research

Posted on Updated on

According to a new report by Allied Market Research titled “Hadoop Market (Hardware, Software, Services and HaaS, End Use Application, and Geography) – Industry Growth Trends and Forecasts Through 2020,” the global hadoop market is expected to grow at a CAGR of 58.2% between 2013 and 2020. The market revenue was estimated to be $2.0 billion in 2013 and is expected to grow to $50.2 billion by 2020. Increase in demand for big data analytics is the major driver for this market.

To request a sample of the report, visit at http://www.alliedmarketresearch.com/hadoop-market

Huge expansion in raw structured and unstructured data and increasing demand for Big Data analytics act as the major driving factors for global Hadoop market as it provides cost effective and faster data processing of Big Data analytics over conventional data analysis tools such as Relational Database Management Systems (RDBMS). Presently, distributed computing and Hadoop platform security issues are hindering the growth of this market. However, with continuous technological growth these issues can be addressed. Moreover, gradual lowering operating costs to provide data management solutions will add to the growth of this market.

Hadoop market, on the basis of type, is segmented into software, hardware and services market. Currently, services market is dominating with a market share of about 50% of the global Hadoop market due to growing necessity of data analysis in various organizations. Hadoop services market is further segmented into consulting, training and outsourcing, integration and deployment, and middleware & support services. Consulting and training & outsourcing segment together accounted for maximum revenue in 2013, whereas, integration and deployment services is the fastest growing services market during the forecast period due to increasing investment in big data analytics and necessity of real time operations. Hadoop software market is projected to have the highest growth rate in the overall global Hadoop market. The increasing venture capital investments lead to addition in number of Hadoop distributors, which is the major reason for growth of Hadoop software market.

Hadoop software market is further segmented as application software, management software, packaged software and performance monitoring software markets. In 2013, application software had generated the highest revenue of the overall global Hadoop software market. The main reason for this is the use of application software by developers to build applications for data analysis. Hadoop packaged software market is expect to grow at a CAGR of 62.9% during the forecast period. One of the reasons being, leading organizations such as MapR Technologies, Hortonworks and Cloudera majorly deal in Hadoop packaged software solutions. Also, Hadoop packaged software provides easier deployment of Hadoop clusters. Thus, Hadoop projects such as MapReduce, Sqoop, Hive and others can be smoothly integrated. Hadoop Hardware Market is segmented as servers, storage, and network equipment markets. In 2013, storage market was leading segment in Hadoop hardware market in terms of revenue, primarily due to social media websites like Facebook, Twitter, and LinkedIn, which add up terabytes of data each day.

Hadoop servers market is expected to have a CAGR of 60.1% during 2013-2020, taking into consideration the volume and velocity at which raw data is expanding. Hadoop technology is currently being implemented the most in government sectors, IT and ITES, and banking, finance and insurance services. Currently, government sector is the largest revenue generating sector in Hadoop end-user application market. However, by 2020, BFSI would supersede government sector and would be the highest revenue-generating segment in the overall Hadoop end user application market. Increasing venture capital funding and rising demand for real time operations in Big Data analytics also contributes to the growth of Hadoop market. Geographical analysis of the market revealed that North America is, and would continue to be the leading revenue generating regional market by 2020. The growth is mainly due to the presence of large number of Hadoop distribution companies & enterprises in the region, and wide adoption of Hadoop technology in North America. Asia Pacific is expected to be the fastest growing regional market at a CAGR at 59.2% during 2013-2020. The report has profiled some of the key players of the market such as Amazon Web Services, Cisco Systems, Cloudera, Inc., Datameer, Inc., Hortonworks, Inc., Karmasphere, Inc., MapR Technologies, Pentaho Corporation, Teradata Corporation and MarkLogic.

Global Anti-counterfeit Packaging Market (Food & Pharmaceuticals) anticipated to reach $142.7 billion by 2020

Posted on Updated on

According to a new report by Allied Market Research titled “Anti-counterfeit Packaging Market in Food and Pharmaceuticals – Technologies, Applications and Global Forecast through 2020”, the global anti-counterfeit packaging market in food and pharmaceuticals is forecast to attain market value of $142.7 billion by 2020 from $57.4 billion in 2013, growing at 13.9% CAGR during 2013 to 2020. Technological advancements and government initiatives to curb counterfeiting is expected to drive the market growth.

To get complete report and the TOC, visit http://www.alliedmarketresearch.com/anti-counterfeit-market

“Counterfeiting practices are rising for food and pharmaceutical products due to globalization of retail sector and dilution of supply chain. Anti-counterfeit packaging market in track and trace technology for product tracking is growing and expected to mature in next few years. Emergence of E-pedigree applications in pharmaceutical is changing the application of RFID technology from real time tracking to real time managing” state Allied Market Research analyst Debbie Shields and Roshan Deshmukh.

View similar studies by this analyst:

Bio-Banks Market http://www.alliedmarketresearch.com/biobanks-market

Anti-counterfeit measurements are taken by companies, so as to minimizing loss due to counterfeiting in-terms of revenue and loyalty. Cost is the significant factor responsible for counterfeiting. However, it is observed that drugs and food items that cost lower are mostly counterfeited mainly due to lower risk involved in terms of penalties. Anti counterfeit packaging is used in both over the counter and prescription based drugs. Increase in demand for over the counter drug, through internet, raises counterfeiting incidence. These threats can be minimized through implementation of RIFD technology, which is collaborated with e-pedigree software.

Leading application of anti-counterfeit packaging includes pharmaceutical drugs, food products, electronic products, apparels etc. Ultra High Frequency RFID technology in collaboration with E-pedigree is providing real time tracking of products with inventory level management during supply chain. The global market for pharmaceutical and food anti-counterfeit packaging is braced by stringent government legislations assigned for specific regions. Pharmaceutical drugs packaging market was valued for $33.7 billion in 2013 and is expected to grow at 13.2% CAGR during 2013-2020. Similarly, surge in demand for packaged food is luring counterfeiters to duplicate the food products. The anti-counterfeit market for packaged food products was valued at $23.7 billion in 2013, is forecast to grow at a CAGR of 14.8% during 2013-2020.

Geographically, anti-counterfeit packaging technology is prevalent in developed countries, as these countries face more problems from duplicate products, especially in food, pharmaceutical and apparels. Increase in awareness for authenticating counterfeit products is reinforcing the anti-counterfeit packaging market. North America is highest revenue generator with $35.6 billion by 2015 and Asia-pacific region is forecast to be the fastest growing market at a CAGR of 15.5% during 2013-2020. This report offers updated trends commercialized in anti-counterfeit packaging market by key companies. Company profiles included in this report are – Alien Technology Corp., Alpvision, Intermec, Zebra Technologies, Inksure Technologies, Holostik, Hologram Industries, Datamax Corp., Avery Dennison and Flint Group.

Astronauts To Be Treated By Dr. Robot

Posted on Updated on

Science has always tried to develop robots with high acumen, speed and accuracy, so that it can accomplish various tasks accurately. It is certainly not easy; however, NASA’s Robonaut is being developed to be a doctor.  Astronauts are trained in basic medical procedures; however, there might be situations where there is a need to perform high end surgical operations. This innovative robot called Robonaut is developed help astronauts in performing surgical operations.

We know that robots are not adroit at being generalist. They are often designed to do one particular task.  However, humans are good at being generalists. Hence, we have always tried to develop multi-tasking technologies that will replicate humans to perform various task. Robots are no exceptions.

R2, the $2.5 million Robonaut 2, will work with the astronauts to shoulder their tedious responsibilities. NASA is also preparingto add telemedicine skills to the new R2.

The basic idea behind Robonaut is to make it competent with general medical procedures that can be performed in the space. Also, difficult medical procedure can be performed with the help of teleoperation. Hence, NASA plans to prepare a list of doctors who would help Robonaut to learn medical procedures in a medical school.

“I would say that within an hour I trained him more than with other students I’m working for a week, so I think that he’s learning really fast,” Dr. ZsoltGarami, of the Houston Methodist Research Institute. Definitely with bright prospects of Robonaut, Medical robotics have a bright future and hence global medical robotics market could witness an upsurge.

£5 Million In Robotic Lab From Dyson

Posted on Updated on

“My generation believed the world would be overrun by robots by the year 2014. We now have the mechanical and electronic capabilities, but robots still lack understanding—seeing and thinking in the way we do. Mastering this will make our lives easier and lead to previously unthinkable technologies,” said James Dyson, founder, Dyson.

Popular for its bagless vacuum cleaners, Dyson, an engineering firm, is all set to invest £5 million in robotic lab situated at imperial college, London. This new robotic lab will help robots to know the world around them and adapt to it.

James Dyson and Prof Andrew Davison of imperial college are working together on robotics since 2005. Robotics vacuum cleaner and domestic robot will be covered in the research that is to be conducted at the lab.

In 2001, Dyson’s robotic vacuum cleaner’s prototype nearly completed its production. However it was taken back by Prof Andrew Davison at the last moment saying that it was way expensive and huge. There are few robotic vacuum cleaners like iRobot’s Roomba and LG’s Hom-Bot in the market.

This five year investment by Dyson will be supplemented by an additional fund of £3 million from other sources.

“A truly intelligent domestic robot needs to complete complex everyday tasks while adapting to a constantly changing environment. “We will research and develop systems that allow machines to both understand and perceive their surroundings – using vision to achieve it,” said Prof Andrew Davison.

Future of global robotics market is bright and is poised to grow. An investment of £250 million was announced by Dyson in January, which will expand the size of its research center at Wiltshire.

Study To Fight Breast Cancer:

Posted on

Dr. Jack Cuzick, leader of the Cancer Research, the U.k’s. Center for Cancer Prevention, headed another examination group from Queen Mary University of London, which contemplated the medication called “anastrozole” and a treatment which served to avert the reoccurrence of breast malignancy in postmenopausal ladies.

Thus, with this study, ladies having a family history of breast malignancy might soon get an enhanced and improved method to forestall breast tumor. Be that as it may, what Dr. Jack Cuzick and his examination group wanted to find is, that the same study might help forestall breast tumor in ladies who hint at developing breast disease in later stage of their life.

The study group concentrated on 3,800 ladies in 18 nations having a family past of breast malignancy. According to the study, anastrozole can help in diminishing the breast malignancy by 53%.

“The biggest surprise of our study was that the side effects were less than expected,” Cuzick said. Anastrozole is not the only drug that can help to reduce the incidence of breast cancer among women. Drugs like tamoxifen and raloxifene are also used to curb breast cancer; however, these drugs have side effects like increased risk for blood clots, stroke and other types of cancer. Although, anastrozole is not free from side effects, it is less severe than other cancer drugs.

“We need to raise awareness that medications to prevent cancer exist. It is vastly underutilized in the world. This study further validates their safety – a major concern for most prescribers,” said Dr. Angel Rodriguez, a breast cancer doctor at Houston’s Methodist Cancer Center.